An epigenetic perspective on neonatal encephalopathy with suspected hypoxic ischaemic encephalopathy

dc.contributor.authorMistry, Priyal
dc.contributor.authorMellet, Juanita
dc.contributor.authorDurandt, Chrisna
dc.contributor.authorSmuts, Izelle
dc.contributor.authorPepper, Michael Sean
dc.contributor.emailmichael.pepper@up.ac.za
dc.date.accessioned2026-02-25T08:26:31Z
dc.date.available2026-02-25T08:26:31Z
dc.date.issued2025-12-08
dc.descriptionDATA AVAILABILITY : No datasets were generated or analysed during the current study.
dc.description.abstractNeonatal encephalopathy with suspected hypoxic ischaemic encephalopathy (NESHIE) is a neurological disorder caused by oxygen deprivation and limited blood flow to a neonate's brain. Although various antenatal and perinatal factors have been identified, their precise role in NESHIE pathogenesis remains unclear. The pathophysiology involves multiple molecular pathways that can be explored using a multi-omics approach, including epigenetics. Epigenetics involves heritable changes in gene expression without altering the DNA sequence, encompassing chemical modifications to DNA and histone proteins, as well as changes mediated by non-coding RNAs (ncRNAs). These epigenetic changes regulate gene expression and can be influenced by environmental factors, offering crucial insights into gene regulation and disease mechanisms. This review examines the role of epigenetic mechanisms in NESHIE, focusing on the modulation of hypoxia-inducible factor-1 alpha (HIF-1α) and ncRNA during hypoxic conditions. Additionally, epigenetic-mediated foetal programming may shed light on how maternal and antenatal risk factors contribute to NESHIE susceptibility. Understanding these epigenetic signatures could advance biomarker discovery and the development of novel therapeutic strategies for NESHIE.
dc.description.departmentImmunology
dc.description.departmentPaediatrics and Child Health
dc.description.librarianam2026
dc.description.sdgSDG-03: Good health and well-being
dc.description.sponsorshipSupported by the South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, the University of Pretoria through the Institute for Cellular and Molecular Medicine, the Bill and Melinda Gates Foundation and the National Research Foundation.
dc.description.urihttps://link.springer.com/journal/13148
dc.identifier.citationMistry, P., Mellet, J., Durandt, C. et al. 2025, 'An epigenetic perspective on neonatal encephalopathy with suspected hypoxic ischaemic encephalopathy', Clinical EpigeneticsClinical Epigenetics, vol. 15, no. 1, art. 15, pp. 1-22. doi : 10.1186/s13148-025-01984-z.
dc.identifier.issn1868-7075 (print)
dc.identifier.issn1868-7083 (online)
dc.identifier.other10.1186/s13148-025-01984-z
dc.identifier.urihttp://hdl.handle.net/2263/108635
dc.language.isoen
dc.publisherBioMed Central
dc.rights© 2025 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND).
dc.subjectNeonatal encephalopathy with suspected hypoxic ischaemic encephalopathy (NESHIE)
dc.subjectEpigenetics
dc.subjectHypoxia-inducible factor-1 alpha (HIF-1α)
dc.subjectFoetal programming
dc.titleAn epigenetic perspective on neonatal encephalopathy with suspected hypoxic ischaemic encephalopathy
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mistry_Epigenetic_2025.pdf
Size:
1.68 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: